FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alan Kivitz

Research Profile

Procedures

Concepts & Ideas

Chemicals & Drugs

Disorders

Devices

Placebos

Co-author Network

Publications

TOP 3
Peter Nash; Sauithree Nayiager; Kurt Oelke; William Palmer; Cristian Rodriguez; Ingrid Delaet; Ayanbola Elegbe; Mark C Genovese; Alan J Kivitz; Charles Ludivico; Michael Corbo
Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study.
Hal M Hoffman; Alan J Kivitz; Yuhwen Soo; Martin L Throne; Niran J Amar; Robert C Cartwright; Steven P Weinstein
Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study.
Loren Laine; Michael H Schiff; Alfonso E Bello; Amy Y Grahn; Alan J Kivitz; Ali S Taha
Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alan Kivitz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Peter Nash; Sauithree Nayiager; Kurt Oelke; William Palmer; Cristian Rodriguez; Ingrid Delaet; Ayanbola Elegbe; Mark C Genovese; Alan J Kivitz; Charles Ludivico; Michael Corbo
Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study.
Arthritis care & research 2013;65(5):718-28.
2012: Hal M Hoffman; Alan J Kivitz; Yuhwen Soo; Martin L Throne; Niran J Amar; Robert C Cartwright; Steven P Weinstein
Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study.
Clinical therapeutics 2012;34(10):2091-103.
2012: Loren Laine; Michael H Schiff; Alfonso E Bello; Amy Y Grahn; Alan J Kivitz; Ali S Taha
Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers.
The American journal of gastroenterology 2012;107(3):379-86.
2011: Philip J Mease; Mark C Genovese; Geoffrey Gladstein; Alan J Kivitz; Christopher Ritchlin; Paul P Tak; Jürgen Wollenhaupt; Orna Bahary; Jean-Claude Becker; Sheila Kelly; Leonard Sigal; Julie Teng; Dafna Gladman
Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.
Arthritis and rheumatism 2011;63(4):939-48.
2011: Stanley B Cohen; John P Donohue; Alan J Kivitz; Liyun Ni; Susanna Proudman; Yu-Nien Sun; Michael S Vincent; Christopher Banfield; Francis X Burch; Deborah Burstein; Debra J Zack
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee.
Arthritis research & therapy 2011;13(4):R125.
2010: Harry K Genant; Klaus Engelke; David A Hanley; Jacques P Brown; M Omizo; H G Bone; Alan J Kivitz; Thomas Fuerst; H Wang; M Austin; C Libanati
Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density.
Bone 2010;47(1):131-9.
2010: Philip J Mease; Nathan Wei; Edward J Fudman; Alan J Kivitz; Joy Schechtman; Robert G Trapp; Kathryn F Hobbs; Maria Greenwald; Antony Hou; Stephen A Bookbinder; Galen E Graham; Craig W Wiesenhutter; Larry Willis; Eric M Ruderman; Joseph Z Forstot; Michael J Maricic; Kathryn H Dao; Charles H Pritchard; Darrell N Fiske; Francis X Burch; H Malin Prupas; Pervin Anklesaria; Alison E Heald
Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.
The Journal of rheumatology 2010;37(4):692-703.
2009: Eva C Koffeman; Mark Genovese; Diane Amox; Elissa Keogh; Ernesto Santana; Eric L Matteson; Arthur Kavanaugh; Jerry A Molitor; Michael H Schiff; James O Posever; Joan M Bathon; Alan J Kivitz; Rodrigo Samodal; Francis Belardi; Carolyn Dennehey; Theo van den Broek; Femke van Wijk; Xiao Zhang; Peter Zieseniss; Tho Le; Berent A Prakken; Gary R Cutter; Salvatore Albani
Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial.
Arthritis and rheumatism 2009;60(11):3207-16.
2008: Alan J Kivitz; Michael Fairfax; Eric A Sheldon; Qinfang Xiang; Beverly A Jones; Arnold Gammaitoni; Errol M Gould
Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Clinical therapeutics 2008;30(12):2366-77.
2008: Daniel J Burge; Stephen A Bookbinder; Alan J Kivitz; Roy M Fleischmann; Cathye Shu; Jeannette Bannink
Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study.
Clinical therapeutics 2008;30(10):1806-16.
2008: Hal M Hoffman; Martin L Throne; N J Amar; Mohamed Sebai; Alan J Kivitz; Arthur Kavanaugh; Steven P Weinstein; Pavel Belomestnov; George D Yancopoulos; Neil stahl; Scott Mellis
Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.
Arthritis and rheumatism 2008;58(8):2443-52.
2008: Jorge Sánchez-Guerrero; Hilda E Fragoso-Loyo; C Michael Neuwelt; Daniel J Wallace; Ellen M Ginzler; Yvonne R S Sherrer; Harris H McIlwain; Pamela G Freeman; Cynthia Aranow; Michelle Petri; Atulya A Deodhar; Ellen Blanton; Susan Manzi; Arthur Kavanaugh; Jeffrey R Lisse; Rosalind Ramsey-Goldman; James D McKay; Alan J Kivitz; Philip J Mease; Anne E Winkler; Leslie E Kahl; Albert H Lee; Richard Furie; C Vibeke Strand; Lillian Lou; Mumtaz Ahmed; Betty Quarles; Kenneth E Schwartz
Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
The Journal of rheumatology 2008;35(8):1567-75.
2008: John C Davis; Désirée van der Heijde; Jurgen Braun; Maxime Dougados; Daniel O Clegg; Alan J Kivitz; R M Fleischmann; Robert D Inman; L Ni; S-L Lin; Wayne Tsuji
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2008;67(3):346-52.
2008: Philip J Mease; Dennis A Revicki; Jacek Szechinski; Maria Greenwald; Alan J Kivitz; Leonor Barile-Fabris; Jatinderpal Kalsi; Jennifer Eames; Marjatta Leirisalo-Repo
Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
The Journal of rheumatology 2008;35(1):20-30.
2007: Alan J Kivitz; Luis R Espinoza; Yvonne R Sherrer; Maria Liu-Dumaw; Christine West
A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
Seminars in arthritis and rheumatism 2007;37(3):164-73.
2007: Michael H Weisman; Harold E Paulus; Francis X Burch; Alan J Kivitz; Joshua Fierer; Meleana Dunn; David R Kerr; Wayne Tsuji; Scott W Baumgartner
A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.
Rheumatology (Oxford, England) 2007;46(7):1122-5.
2007: Mark C Genovese; Philip J Mease; Glen T D Thomson; Alan J Kivitz; Renee J Perdok; Mark A Weinberg; John Medich; Eric H Sasso
Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.
The Journal of rheumatology 2007;34(5):1040-50.
2007: Alan J Kivitz; Oscar Segurado
HUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab.
Expert review of medical devices 2007;4(2):109-16.
2007: Jeffrey L Kaine; Alan J Kivitz; Charles Birbara; Allison Y Luo
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
The Journal of rheumatology 2007;34(2):272-9.
2006: Alan J Kivitz; Steven Cohen; James Edward Dowd; William Edwards; Suman Thakker; Frank R Wellborne; Cheryl L Renz; Oscar Segurado
Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial.
Clinical therapeutics 2006;28(10):1619-29.
2006: Désirée van der Heijde; Alan J Kivitz; Michael H Schiff; Joachim Sieper; B A C Dijkmans; Jürgen Braun; Maxime Dougados; John D Reveille; Robert L Wong; Hartmut Kupper; John C Davis
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2006;54(7):2136-46.
2006: Philip J Mease; Alan J Kivitz; Francis X Burch; Evan L Siegel; Stanley B Cohen; Peter A Ory; David Salonen; Joel Rubenstein; John T Sharp; Meleana Dunn; Wayne Tsuji
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
The Journal of rheumatology 2006;33(4):712-21.
2006: Alan J Kivitz; Carl Ma; Harry Ahdieh; Bradley S Galer
A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Clinical therapeutics 2006;28(3):352-64.
2006: Michael R McClung; E Michael Lewiecki; Stanley B Cohen; Michael A Bolognese; Grattan C Woodson; Alfred H Moffett; Munro Peacock; Paul D Miller; Samuel N Lederman; Charles H Chesnut; Douglas Lain; Alan J Kivitz; Donna L Holloway; Charlie Zhang; Mark C Peterson; Pirow J Bekker
Denosumab in postmenopausal women with low bone mineral density.
The New England journal of medicine 2006;354(8):821-31.
2006: Gary W Williams; Alan J Kivitz; Mark T Brown; Kenneth M Verburg
A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
Clinical therapeutics 2006;28(2):204-21.
2005: Thomas J Schnitzer; Alan J Kivitz; Robert S Lipetz; Nick Sanders; Angela Hee
Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
Arthritis and rheumatism 2005;53(6):827-37.
2005: Ronald Emkey; William Koltun; Kathleen M Beusterien; Larry Seidman; Alan J Kivitz; Vipul Devas; Daiva Masanauskaite
Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO).
Current medical research and opinion 2005;21(12):1895-903.
2005: John C Davis; Désirée van der Heijde; Jurgen Braun; Maxime Dougados; John J Cush; D Clegg; Robert D Inman; Alan J Kivitz; L Zhou; A Solinger; Wayne Tsuji
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.
Annals of the rheumatic diseases 2005;64(11):1557-62.
2005: John D Bradley; Alex Dmitrienko; Alan J Kivitz; Oscar S Gluck; Arthur L Weaver; Craig Wiesenhutter; Stephen L Myers; Gregory D Sides
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.
The Journal of rheumatology 2005;32(3):417-23.
2005: James R Sowers; William B White; Bertram Pitt; Andrew Whelton; Lee S Simon; Nathaniel Winer; Alan J Kivitz; Hein van Ingen; Thomas Brabant; John G Fort
The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Archives of internal medicine 2005;165(2):161-8.
2005: J van Holten; Karel Pavelka; J Vencovsky; H Stahl; Blaz Rozman; M Genovese; Alan J Kivitz; J Alvaro; George Nuki; D E Furst; Gabriel Herrero-Beaumont; I B McInnes; P Musikic; P P Tak
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(1):64-9.
2004: Wendy P Battisti; Nathaniel P Katz; Arthur L Weaver; Alan K. Matsumoto; Alan J Kivitz; Adam B Polis; Gregory P Geba
Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials.
The journal of pain : official journal of the American Pain Society 2004;5(9):511-20.
2004: Philip J Mease; Alan J Kivitz; Francis X Burch; Evan L Siegel; Stanley B Cohen; Peter A Ory; David Salonen; Joel Rubenstein; John T Sharp; Wayne Tsuji
Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
Arthritis and rheumatism 2004;50(7):2264-72.
2004: Alan J Kivitz; S Nayiager; T Schimansky; A Gimona; H J Thurston; C Hawkey
Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.
Alimentary pharmacology & therapeutics 2004;19(11):1189-98.
2004: Alan J Kivitz; Maria W Greenwald; Stanley B Cohen; Adam B Polis; Daryl K Najarian; Mary E Dixon; Robert A Moidel; Jerry A Green; Herbert S B Baraf; Richard A Petruschke; Alan K. Matsumoto; Gregory P Geba
Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
Journal of the American Geriatrics Society 2004;52(5):666-74.
2003: John C Davis; Désirée van der Heijde; Jurgen Braun; Maxime Dougados; John J Cush; Daniel O Clegg; Alan J Kivitz; Roy Fleischmann; Robert Inman; Wayne Tsuji
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
Arthritis and rheumatism 2003;48(11):3230-6.
2003: Frederick T Murphy; Alan J Kivitz; Earl E Sands
Management of postmenopausal osteoporosis.
The Journal of the American Osteopathic Association 2003;103(10 Suppl 6):S6-11.
2003: Jay L Goldstein; Alan J Kivitz; Kenneth M Verburg; David P Recker; R C Palmer; Jeffrey D Kent
A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects.
Alimentary pharmacology & therapeutics 2003;18(1):125-32.
2003: Arthur Kavanaugh; Mark Genovese; Jan Baughman; Alan J Kivitz; Ken J Bulpitt; Nancy Olsen; Michael Weisman; Eric Matteson; Daniel Furst; Ronald van Vollenhoven; James Anderson; Stanley Cohen; Nathan Wei; Jan Meijerink; Cindy Jacobs; Simonetta Mocci
Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.
The Journal of rheumatology 2003;30(3):449-54.
2002: Alan J Kivitz; Glenn Eisen; William W Zhao; Terry Bevirt; David P Recker
Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
The Journal of family practice 2002;51(6):530-7.
2001: Alan J Kivitz; Roland W Moskowitz; E Woods; Richard C Hubbard; Kenneth M Verburg; James B Lefkowith; G Steven Geis
Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip.
The Journal of international medical research 2001;29(6):467-79.
1999: Lee S Simon; A L Weaver; D Y Graham; Alan J Kivitz; P E Lipsky; Richard C Hubbard; Peter C Isakson; Kenneth M Verburg; SS Yu; William W Zhao; G Steven Geis
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1999;282(20):1921-8.